THURMAN RANDY H 4
4 · Outlook Therapeutics, Inc. · Filed Sep 15, 2020
Insider Transaction Report
Form 4
THURMAN RANDY H
Director
Transactions
- Purchase
Common Stock
2020-09-14$0.62/sh+10,000$6,200→ 11,875 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Reflects a 1-for-8 reverse stock split effected by the Issuer on March 15, 2019 (the "Split Date"). The Reporting Person's previous ownership of 15,000 shares of common stock was adjusted to 1,875 shares of Common Stock on the Split Date.